Enrollment Begun on Phase II Clinical Trial in Crohn's Disease
TMCnet.com,
] Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today enrollment of the first two patients in an investigator-initiated…
] Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today enrollment of the first two patients in an investigator-initiated…
SAN DIEGO--(Business Wire)--Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today enrollment of the first two patients in an…
SAN DIEGO--(BUSINESS WIRE)-- Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today enrollment of the first two patients in…
11 minutes ago Done SAN DIEGO--(BUSINESS WIRE)-- Cytori Therapeutics, Inc. (CYTX) announced today enrollment of the first two…
Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today enrollment of the first two patients in an investigator-initiated…
SAN DIEGO--( BUSINESS WIRE )--Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today enrollment of the first two patients in…
SAN DIEGO--(Business Wire)--Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today the publication of the results of a pilot…
Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today the publication of the results of a pilot clinical trial of Cytori…
SAN DIEGO--( BUSINESS WIRE )--Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today the publication of the results of a…